Cardinal Health's dose calibrator receives FDA clearance
Dublin, Ohio-based company Cardinal Health Inc. has received FDA 510(k) clearance for the Nuclear Associates' Calrad Mark VI dose calibrator.
The product will be available through the company's Radiation Management Services business, which supports health imaging and therapy fields. The Nuclear Associates brand includes radiation detection instruments and information management software.
Features of the Calrad Mark VI include a touch screen interface; Microsoft XP embedded system; built-in, menu-driven software for automated linearity; quality assurance protocols for daily and quarterly checks; and a kit inventory control for remembering activity and volume in prepared kits and an extensive isotope library.
The product will be available through the company's Radiation Management Services business, which supports health imaging and therapy fields. The Nuclear Associates brand includes radiation detection instruments and information management software.
Features of the Calrad Mark VI include a touch screen interface; Microsoft XP embedded system; built-in, menu-driven software for automated linearity; quality assurance protocols for daily and quarterly checks; and a kit inventory control for remembering activity and volume in prepared kits and an extensive isotope library.